Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia | Zendy

Mulualem Tadesse | Zendy; Dossegnaw Aragaw | Zendy; Belayneh Dimah | Zendy; Feyisa Efa | Zendy; Kedir Abdella | Zendy; Wakjira Kebede | Zendy; Ketema Abdissa | Zendy; Gemeda Abebe | Zendy

Open Access

Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia

Author(s) -

Mulualem Tadesse,

Dossegnaw Aragaw,

Belayneh Dimah,

Feyisa Efa,

Kedir Abdella,

Wakjira Kebede,

Ketema Abdissa,

Gemeda Abebe

Publication year - 2016

Publication title -

international journal of mycobacteriology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.53

H-Index - 20

eISSN - 2212-554X

pISSN - 2212-5531

DOI - 10.1016/j.ijmyco.2016.02.009

Subject(s) - inha , rpob , isoniazid , mycobacterium tuberculosis , tuberculosis , genotype , rifampicin , drug resistance , gene mutation , gene , biology , mutation , multiple drug resistance , virology , medicine , microbiology and biotechnology , genetics , pathology

The nature and frequency of mutations in rifampicin (RIF) and isoniazid (INH) resistant Mycobacterium tuberculosis isolates vary considerably according to geographic locations. However, information regarding specific mutational patterns in Ethiopia remains limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research